Cargando…

Validity of first-time diagnoses of congenital epidermolysis bullosa in the Danish National Patient Registry and the Danish Pathology Registry

PURPOSE: Congenital epidermolysis bullosa (CEB) is a group of rare monogenic genodermatoses. Phenotypically, the diseases vary in both severity and dissemination, which complicates studies of their epidemiology. To investigate the potential of using the Danish National Patient Registry (DNPR) for ep...

Descripción completa

Detalles Bibliográficos
Autores principales: Kristensen, Mattias Hedegaard, Schmidt, Sigrún Alba Jóhannesdóttir, Kibsgaard, Line, Mogensen, Mette, Sommerlund, Mette, Koppelhus, Uffe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340365/
https://www.ncbi.nlm.nih.gov/pubmed/30697082
http://dx.doi.org/10.2147/CLEP.S184742
_version_ 1783388782559494144
author Kristensen, Mattias Hedegaard
Schmidt, Sigrún Alba Jóhannesdóttir
Kibsgaard, Line
Mogensen, Mette
Sommerlund, Mette
Koppelhus, Uffe
author_facet Kristensen, Mattias Hedegaard
Schmidt, Sigrún Alba Jóhannesdóttir
Kibsgaard, Line
Mogensen, Mette
Sommerlund, Mette
Koppelhus, Uffe
author_sort Kristensen, Mattias Hedegaard
collection PubMed
description PURPOSE: Congenital epidermolysis bullosa (CEB) is a group of rare monogenic genodermatoses. Phenotypically, the diseases vary in both severity and dissemination, which complicates studies of their epidemiology. To investigate the potential of using the Danish National Patient Registry (DNPR) for epidemiological research on CEB, we examined the positive predictive value (PPV) of a first-time diagnosis of CEB. METHODS: We identified patients with a record of CEB in DNPR and the Danish Pathology Registry (DPR) during January 1, 1977, until December 31, 2015. We restricted diagnoses from two dermatological departments and one regional hospital. Diagnoses in the DNPR are coded by the eighth and tenth revisions of the ICD (ICD-8 and ICD-10) and in the DPR by the Systematized Nomenclature of Medicine (SNOMED). We used clinical description in medical records, family history, histological findings, and molecular genetic investigations to validate diagnoses and classified them as rejected and confirmed. We estimated PPVs for any diagnosis, according to coding systems used, and for additional subdivisions of ICD-10 codes. RESULTS: We identified 116 cases from the hospital departments investigated and evaluated 96 medical records for validity. The overall PPV for probable CEB was 62.5% (95% CI: 52.5–71.5). For ICD-8, ICD-10, and SNOMED codes, the PPVs were 30.8% (95% CI: 11.4–57.7), 76.7% (95% CI: 65.8–84.9), and 0.0% (95% CI: 0.0–21.7), respectively. For the ICD-10 codes, we found the highest PPVs for diagnoses arising from the dermatological departments. For subdivisions of ICD-10 codes, PPVs were high for epidermolysis bullosa simplex and dystrophica. CONCLUSION: The PPVs for first-time diagnoses of CEB registered in the two Danish nationwide registries investigated, DNPR and DPR, ranged from low to average. We therefore recommend that these data be used with caution and restricted to ICD-10 diagnoses from specialized dermatological departments.
format Online
Article
Text
id pubmed-6340365
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-63403652019-01-29 Validity of first-time diagnoses of congenital epidermolysis bullosa in the Danish National Patient Registry and the Danish Pathology Registry Kristensen, Mattias Hedegaard Schmidt, Sigrún Alba Jóhannesdóttir Kibsgaard, Line Mogensen, Mette Sommerlund, Mette Koppelhus, Uffe Clin Epidemiol Original Research PURPOSE: Congenital epidermolysis bullosa (CEB) is a group of rare monogenic genodermatoses. Phenotypically, the diseases vary in both severity and dissemination, which complicates studies of their epidemiology. To investigate the potential of using the Danish National Patient Registry (DNPR) for epidemiological research on CEB, we examined the positive predictive value (PPV) of a first-time diagnosis of CEB. METHODS: We identified patients with a record of CEB in DNPR and the Danish Pathology Registry (DPR) during January 1, 1977, until December 31, 2015. We restricted diagnoses from two dermatological departments and one regional hospital. Diagnoses in the DNPR are coded by the eighth and tenth revisions of the ICD (ICD-8 and ICD-10) and in the DPR by the Systematized Nomenclature of Medicine (SNOMED). We used clinical description in medical records, family history, histological findings, and molecular genetic investigations to validate diagnoses and classified them as rejected and confirmed. We estimated PPVs for any diagnosis, according to coding systems used, and for additional subdivisions of ICD-10 codes. RESULTS: We identified 116 cases from the hospital departments investigated and evaluated 96 medical records for validity. The overall PPV for probable CEB was 62.5% (95% CI: 52.5–71.5). For ICD-8, ICD-10, and SNOMED codes, the PPVs were 30.8% (95% CI: 11.4–57.7), 76.7% (95% CI: 65.8–84.9), and 0.0% (95% CI: 0.0–21.7), respectively. For the ICD-10 codes, we found the highest PPVs for diagnoses arising from the dermatological departments. For subdivisions of ICD-10 codes, PPVs were high for epidermolysis bullosa simplex and dystrophica. CONCLUSION: The PPVs for first-time diagnoses of CEB registered in the two Danish nationwide registries investigated, DNPR and DPR, ranged from low to average. We therefore recommend that these data be used with caution and restricted to ICD-10 diagnoses from specialized dermatological departments. Dove Medical Press 2019-01-17 /pmc/articles/PMC6340365/ /pubmed/30697082 http://dx.doi.org/10.2147/CLEP.S184742 Text en © 2019 Kristensen et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Kristensen, Mattias Hedegaard
Schmidt, Sigrún Alba Jóhannesdóttir
Kibsgaard, Line
Mogensen, Mette
Sommerlund, Mette
Koppelhus, Uffe
Validity of first-time diagnoses of congenital epidermolysis bullosa in the Danish National Patient Registry and the Danish Pathology Registry
title Validity of first-time diagnoses of congenital epidermolysis bullosa in the Danish National Patient Registry and the Danish Pathology Registry
title_full Validity of first-time diagnoses of congenital epidermolysis bullosa in the Danish National Patient Registry and the Danish Pathology Registry
title_fullStr Validity of first-time diagnoses of congenital epidermolysis bullosa in the Danish National Patient Registry and the Danish Pathology Registry
title_full_unstemmed Validity of first-time diagnoses of congenital epidermolysis bullosa in the Danish National Patient Registry and the Danish Pathology Registry
title_short Validity of first-time diagnoses of congenital epidermolysis bullosa in the Danish National Patient Registry and the Danish Pathology Registry
title_sort validity of first-time diagnoses of congenital epidermolysis bullosa in the danish national patient registry and the danish pathology registry
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340365/
https://www.ncbi.nlm.nih.gov/pubmed/30697082
http://dx.doi.org/10.2147/CLEP.S184742
work_keys_str_mv AT kristensenmattiashedegaard validityoffirsttimediagnosesofcongenitalepidermolysisbullosainthedanishnationalpatientregistryandthedanishpathologyregistry
AT schmidtsigrunalbajohannesdottir validityoffirsttimediagnosesofcongenitalepidermolysisbullosainthedanishnationalpatientregistryandthedanishpathologyregistry
AT kibsgaardline validityoffirsttimediagnosesofcongenitalepidermolysisbullosainthedanishnationalpatientregistryandthedanishpathologyregistry
AT mogensenmette validityoffirsttimediagnosesofcongenitalepidermolysisbullosainthedanishnationalpatientregistryandthedanishpathologyregistry
AT sommerlundmette validityoffirsttimediagnosesofcongenitalepidermolysisbullosainthedanishnationalpatientregistryandthedanishpathologyregistry
AT koppelhusuffe validityoffirsttimediagnosesofcongenitalepidermolysisbullosainthedanishnationalpatientregistryandthedanishpathologyregistry